Differential Gene Expression Analysis Reveals Activation of Growth Promoting Signaling Pathways by Tenascin-C

Tenascin-C is an adhesion-modulating extracellular matrix molecule that is highly expressed in tumor stroma and stimulates tumor cell proliferation. Adhesion of T98G glioblastoma cells to a fibronectin substratum is inhibited by tenascin-C. To address the mechanism of action, we performed a RNA expression analysis of T89G cells grown in the presence or absence of tenascin-C and found that tenascin-C down-regulates tropomyosin-1. Upon overexpression of tropomyosin-1, cell spreading on a fibronectin/tenascin-C substratum was restored, indicating that tenascin-C destabilizes actin stress fibers through down-regulation of tropomyosin-1. Tenascin-C also increased the expression of the endothelin receptor type A and stimulated the corresponding mitogen-activated protein kinase signaling pathway, which triggers extracellular signal-regulated kinase 1/2 phosphorylation and c-Fos expression. Tenascin-C additionally caused down-regulation of the Wnt inhibitor Dickkopf 1. In consequence, Wnt signaling was enhanced through stabilization of β-catenin and stimulated the expression of the β-catenin target Id2. Finally, our in vivo data derived from astrocytoma tissue arrays link increased tenascin-C and Id2 expression with high malignancy. Because increased endothelin and Wnt signaling, as well as reduced tropomyosin-1 expression, are closely linked to transformation and tumorigenesis, we suggest that tenascin-C specifically modulates these signaling pathways to enhance proliferation of glioma cells.

[1]  R. Nusse,et al.  Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Bob Y. Liu,et al.  Mammary gland development requires syndecan-1 to create a β-catenin/TCF-responsive mammary epithelial subpopulation , 2003, Oncogene.

[3]  S. Dedhar,et al.  The role of integrin-linked kinase (ILK) in cancer progression , 2003, Cancer and Metastasis Reviews.

[4]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[5]  Eytan Domany,et al.  Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. , 2003, Cancer research.

[6]  M. Willingham,et al.  Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors , 2003, Oncogene.

[7]  R. Ganz,et al.  Early osteoarthritic changes of human femoral head cartilage subsequent to femoro-acetabular impingement. , 2003, Osteoarthritis and cartilage.

[8]  Matthias Chiquet,et al.  Tenascins: regulation and putative functions during pathological stress , 2003, The Journal of pathology.

[9]  Monilola A. Olayioye,et al.  Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4 , 2003, Oncogene.

[10]  J. Shaw,et al.  Mdm20 protein functions with Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin–actin interactions in budding yeast , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Hans Clevers,et al.  Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.

[12]  R. Alani,et al.  Id proteins in cell growth and tumorigenesis. , 2003, Cancer cell.

[13]  R. Treisman,et al.  Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MAL , 2003, Cell.

[14]  Sakae Tanaka,et al.  Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing. , 2003, Molecular biology of the cell.

[15]  G. Schevzov,et al.  High‐molecular‐weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors , 2003, Glia.

[16]  Thomas D Pollard,et al.  Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.

[17]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[18]  M. Brown-Luedi,et al.  Tenascin-C signaling through induction of 14-3-3 tau , 2003, The Journal of cell biology.

[19]  A. Aplin.  Cell adhesion molecule regulation of nucleocytoplasmic trafficking , 2003, FEBS letters.

[20]  Christof Niehrs,et al.  Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. , 2003, Gene.

[21]  J. Condeelis,et al.  Spatial regulation of actin dynamics: a tropomyosin-free, actin-rich compartment at the leading edge , 2002, Journal of Cell Science.

[22]  F. Baas,et al.  Expression and distribution of id helix‐loop‐helix proteins in human astrocytic tumors , 2002, Glia.

[23]  Hans Clevers,et al.  Wnt Signaling Controls the Phosphorylation Status of β-Catenin* , 2002, The Journal of Biological Chemistry.

[24]  Martin A. Schwartz,et al.  Networks and crosstalk: integrin signalling spreads , 2002, Nature Cell Biology.

[25]  C. Der,et al.  Opposing Roles of the Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades in Ras-Mediated Downregulation of Tropomyosin , 2002, Molecular and Cellular Biology.

[26]  Margareta M. Mueller,et al.  Clinical impact and functional aspects of tenascin‐C expression during glioma progression , 2002, International journal of cancer.

[27]  H. Clevers,et al.  Wnt signals are transmitted through N‐terminally dephosphorylated β‐catenin , 2002 .

[28]  E. Hara,et al.  Id proteins in cell cycle control and cellular senescence , 2001, Oncogene.

[29]  J. Moyano,et al.  Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. , 2001, Cancer research.

[30]  Wayne A. Phillips,et al.  Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma* , 2001, The Journal of Biological Chemistry.

[31]  John Armstrong,et al.  Cytokine-Specific Transcriptional Regulation Through an IL-5Rα Interacting Protein , 2001, Science.

[32]  Stuart A. Aaronson,et al.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow , 2001, Nature Cell Biology.

[33]  D. Helfman,et al.  Cytoskeletal changes in cell transformation and tumorigenesis. , 2001, Current opinion in genetics & development.

[34]  A. Penzo-Méndez,et al.  The C‐terminal cytoplasmic Lys‐Thr‐X‐X‐X‐Trp motif in frizzled receptors mediates Wnt/β‐catenin signalling , 2000, The EMBO journal.

[35]  J. Schwarzbauer,et al.  Tenascin-C Suppresses Rho Activation , 2000, The Journal of cell biology.

[36]  M. Sheng,et al.  Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2 , 2000, Nature.

[37]  S. Tumova,et al.  Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. , 2000, Archives of biochemistry and biophysics.

[38]  H. Clevers,et al.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. , 1999, Science.

[39]  N. Harindranath,et al.  Suppression of src-induced transformed phenotype by expression of tropomyosin-1 , 1999, Oncogene.

[40]  K. Catt,et al.  Endothelins as Autocrine Regulators of Tumor Cell Growth , 1998, Trends in Endocrinology & Metabolism.

[41]  T. Austin,et al.  A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. , 1997, Blood.

[42]  Mariann Bienz,et al.  LEF-1, a Nuclear Factor Coordinating Signaling Inputs from wingless and decapentaplegic , 1997, Cell.

[43]  P. Kantoff,et al.  Two differentially expressed genes in normal human prostate tissue and in carcinoma. , 1996, Cancer research.

[44]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[45]  M. Sokolovsky,et al.  Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell lines. , 1993, European journal of pharmacology.

[46]  D. Salomon,et al.  Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. , 1990, Cancer research.

[47]  F. Giancotti,et al.  Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells , 1990, Cell.

[48]  M. Noda,et al.  Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. , 1985, Molecular and cellular biology.

[49]  R. Juliano,et al.  Integrin Signaling , 2005, Cancer and Metastasis Reviews.

[50]  Hans C Clevers,et al.  Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. , 2002, EMBO reports.

[51]  S. Rockman,et al.  Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. , 2001, The Journal of biological chemistry.

[52]  E. Ruoslahti,et al.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. , 1990, Cell.